Ganja Growers Association Urges Jamaica to Move Quickly After US Cannabis Rescheduling

KINGSTON, Jamaica — The Ganja Growers and Producers Association of Jamaica (GGPAJ) has applauded Washington's decision to move cannabis from Schedule I to Schedule III under United States federal law, calling the policy adjustment a turning point that brings both fresh openings and pressing risks for the local ganja sector.

In a press release issued on Tuesday, the association said the rescheduling, prompted by recent US policy direction, should loosen restrictions on scientific research, widen access to banking and financial services, and further establish cannabis as a properly regulated medical product inside the world's biggest economy.

Still, GGPAJ argued that the international progress raises the bar for Jamaica's capacity to compete and remain a serious participant in the changing global trade.

"This materially changes the operating environment for the global ganja industry — and Jamaican farmers need to read it as both an opening and a warning," said Maurice Ellis, president of GGPAJ.

The organisation expects the US move to speed up medical research and clinical validation, drive product development and innovation, and attract institutional investment and cross-border partnerships. For Jamaica, that could mean stronger demand for compliant, traceable, high-quality ganja, especially in the medicinal and export categories.

At the same time, GGPAJ noted that operators in the United States stand to gain better access to capital and banking, more favourable tax treatment, greater scalability and tighter supply-chain integration. That, the association said, is likely to push the industry toward faster consolidation and lower production costs — a competitive squeeze that many Jamaican growers, particularly traditional and small-scale farmers, are not yet ready to handle.

"The recent rescheduling of cannabis in the United States presents a significant opportunity for jurisdictions that can move decisively and deploy capital at scale to capture emerging market share. However, it also heightens the competitive stakes globally," said Andray McKenzie, vice president of GGPAJ.

"Despite Jamaica's strong brand equity and deep cultural legacy in cannabis, there is a real risk that the country could be relegated to low-margin participation if it does not rapidly strengthen its regulatory efficiency, industrial capacity and commercial positioning," McKenzie added.

He said financial institutions would be central to the next phase, particularly through dedicated funding lines tailored to research, manufacturing and industry scale-up. "The window for action is narrow, and jurisdictions that respond with speed and coordination will secure disproportionate value in the evolving global market. Jamaica has the foundational assets to lead, but this will require urgent alignment of policy, capital and industry to fully realise its potential," McKenzie said.

GGPAJ stressed that the country cannot afford to drift. "The global market is about to professionalise rapidly, and Jamaica is behind on regulatory efficiency and farmer inclusion," Ellis said.

The association welcomed recent amendments to local regulations but said licensing frameworks still need to be simpler and more accessible. It is pressing for stronger medicinal cannabis product innovation, development and approvals; genuine inclusion of traditional and sacramental growers; alignment with international compliance and export standards; and stronger transition support so small-scale farmers can compete.

GGPAJ underlined that Jamaica's global ganja identity is anchored in its cultural, traditional and sacramental heritage, and said those stakeholders must stay at the centre of the sector's growth. Without deliberate inclusion and policy reform, the association warned, the very farmers who carried the industry for generations could be shut out of its economic future.

"The advantage will go to jurisdictions that can organise quickly," Ellis said.